Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Avista Public Acquisition Corp. II | Executive Vice President | No securities beneficially owned | 0 | Aug 9, 2021 | Direct | ||
RVL Pharmaceuticals plc | Director, 10%+ Owner | Ordinary Shares | 0 | $0.03 | Jan 27, 2023 | By Avista Capital investment fund |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RVLP | RVL Pharmaceuticals plc | Jan 27, 2023 | 1 | $0 | 4 | Jan 30, 2023 | Director, 10%+ Owner |
RVLP | RVL Pharmaceuticals plc | Aug 8, 2022 | 1 | $12.4M | 4 | Aug 9, 2022 | Director, 10%+ Owner |
OABI | Avista Public Acquisition Corp. II | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | Executive Vice President |